Covestor’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10K Buy
716
+61
+9% +$822 0.01% 1378
2025
Q4
$7K Buy
655
+3
+0.5% +$34 ﹤0.01% 1761
2025
Q3
$7K Buy
652
+648
+16,200% +$7.59K ﹤0.01% 1786
2025
Q2
$0 Sell
4
-288
-99% -$3.62K ﹤0.01% 2200
2025
Q1
$4K Buy
292
+14
+5% +$219 ﹤0.01% 1745
2024
Q4
$4K Sell
278
-19
-6% -$376 ﹤0.01% 1743
2024
Q3
$7K Buy
297
+6
+2% +$137 ﹤0.01% 1684
2024
Q2
$6K Buy
291
+1
+0.3% +$19 ﹤0.01% 1740
2024
Q1
$6K Buy
290
+14
+5% +$271 ﹤0.01% 1763
2023
Q4
$6K Buy
276
+45
+19% +$929 ﹤0.01% 1745
2023
Q3
$5K Buy
231
+6
+3% +$136 ﹤0.01% 1712
2023
Q2
$6K Buy
225
+66
+42% +$1.74K ﹤0.01% 1666
2023
Q1
$5K Sell
159
-24
-13% -$697 ﹤0.01% 1547
2022
Q4
$5K Buy
183
+37
+25% +$905 ﹤0.01% 1552
2022
Q3
$3K Buy
146
+90
+161% +$2.35K ﹤0.01% 1600
2022
Q2
$2K Buy
56
+46
+460% +$1.32K ﹤0.01% 1586
2022
Q1
$0 Sell
10
-58
-85% -$1.87K ﹤0.01% 2094
2021
Q4
$2K Buy
+68
New +$2.2K ﹤0.01% 1517

Other funds holding AVNS

Covestor's AVNS Position: Q1 2026 in Review

Covestor increased its Avanos Medical (AVNS) stake by 9.3% in Q1 2026, buying an estimated $822 and bringing the position to 716 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1378.

Covestor first reported a position in AVNS in Q4 2021 and has held it in 18 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Covestor held 716 shares of Avanos Medical worth $10K as of Q1 2026.
  • Covestor bought 61 Avanos Medical shares in Q1 2026, an estimated $822.
  • Avanos Medical made up 0.01% of Covestor's portfolio in Q1 2026, its #1378 holding.
  • Covestor first reported a position in Avanos Medical in Q4 2021 and has held it in 18 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.